Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,632 Skin Cancer
clinical trials

Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Springfield, MO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Springfield, MO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Springfield, OH
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Stevens Point, WI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Stillwater, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Toledo, OH
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Tulsa, OK
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Warren, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Wichita, KS
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Willmar, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Zanesville, OH
Click here to add this to my saved trials
Stage IV Resectable Melanoma Clinical Trial
Stage IV Surgery Versus Best Medical Therapy
Status: Enrolling
Updated: 8/13/2012
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Stage IV Resectable Melanoma Clinical Trial
Stage IV Surgery Versus Best Medical Therapy
Status: Enrolling
Updated: 8/13/2012
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum
Status: Enrolling, Phase I
Updated: 3/14/2014
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
Status: Enrolling
Updated: 6/11/2013
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
Status: Enrolling
Updated: 6/11/2013
mi
from
Pasadena, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 10/22/2013
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Melanoma Clinical Trial
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
Status: Enrolling, Phase I, II
Updated: 9/8/2015
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 12/6/2013
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 12/6/2013
mi
from
Rochester, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma
Status: Enrolling
Updated: 11/13/2012
mi
from
Seattle, WA
Click here to add this to my saved trials
Melanoma Clinical Trial
Study to Compare the Effect of Ipilimumab Retreatment With Chemotherapy in Advanced Melanoma
Status: Enrolling
Updated: 10/15/2013
mi
from
Dallas, TX
Click here to add this to my saved trials
Melanoma Clinical Trial
Study to Compare the Effect of Ipilimumab Retreatment With Chemotherapy in Advanced Melanoma
Status: Enrolling
Updated: 10/15/2013
mi
from
Prairie Village, KS
Click here to add this to my saved trials
Melanoma Clinical Trial
Study to Compare the Effect of Ipilimumab Retreatment With Chemotherapy in Advanced Melanoma
Status: Enrolling
Updated: 10/15/2013
mi
from
Wichita, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases
Status: Enrolling, Phase
Updated: 2/5/2014
mi
from
Cleveland, OH
Click here to add this to my saved trials
Metastatic or Unresectable Cutaneous Melanoma Clinical Trial
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
Status: Enrolling, Phase III
Updated: 1/15/2015
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Metastatic or Unresectable Cutaneous Melanoma Clinical Trial
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
Status: Enrolling, Phase III
Updated: 1/15/2015
mi
from
Mobile, AL
Click here to add this to my saved trials
Locally Advanced or Metastatic NRAS Mutant Melanoma Clinical Trial
A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma
Status: Enrolling, Phase I, II
Updated: 11/20/2015
mi
from
Tampa, FL
Click here to add this to my saved trials
Stage IV Skin Melanoma Clinical Trial
Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab Therapy
Status: Enrolling
Updated: 5/15/2015
mi
from
Rochester, MN
Click here to add this to my saved trials
Melanoma Clinical Trial
Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab
Status: Enrolling
Updated: 3/28/2013
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib
Status: Enrolling
Updated: 3/11/2013
mi
from
Atlanta, GA
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Lebanon, NH
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Little Rock, AR
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Chandler, AZ
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Dallas, TX
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Rochester, MN
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Status: Enrolling, Phase III
Updated: 12/8/2015
mi
from
Sacramento, CA
Click here to add this to my saved trials
Melanoma Clinical Trial
Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma
Status: Enrolling
Updated: 6/25/2013
mi
from
Boston, MA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
mi
from
La Jolla, CA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
mi
from
Lebanon, NH
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/29/2014
mi
from
Tucson, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/23/2015
mi
from
Bloomington, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/23/2015
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/23/2015
mi
from
Philadephia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/23/2015
mi
from
Woodbury, MN
Click here to add this to my saved trials
Oncology Clinical Trial
LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations
Status: Enrolling, Phase II
Updated: 8/26/2015
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Status: Enrolling
Updated: 6/24/2013
mi
from
Morristown, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Dinaciclib in Treating Patients With Advanced Melanoma
Status: Enrolling
Updated: 1/15/2013
mi
from
Boston, MA
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 11/5/2015
mi
from
St. Louis, MO
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 11/5/2015
mi
from
Chicago, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Honolulu, HI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Ames, IA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Baltimore, MD
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Billings, MT
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Bismarck, ND
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Butte, MT
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Fort Scott, KS
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Johnson Creek, WI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Kalispell, MT
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Kansas City, MO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Manitowoc, WI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Maywood, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
McPherson, KS
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
New Ulm, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Newton, KS
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Pratt, KS
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Springfield, MO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Stillwater, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Waukesha, WI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 9/16/2014
mi
from
Weston, WI
Click here to add this to my saved trials
Melanoma Clinical Trial
A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma
Status: Enrolling, Phase I
Updated: 5/6/2014
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Immunotherapy Study for Patients With Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 10/28/2015
mi
from
Knoxville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Hsp90 Inhibitor AT13387, Dabrafenib, and Trametinib in Treating Patients With Recurrent Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase I
Updated: 12/24/2015
mi
from
Tampa, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Status: Enrolling, Phase II
Updated: 5/29/2015
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists
Status: Enrolling, Phase I, II
Updated: 7/30/2015
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Melanoma Clinical Trial
A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma
Status: Enrolling, Phase I
Updated: 10/9/2015
mi
from
Dallas, TX
Click here to add this to my saved trials
Stage III Unresectable or Stage IV Advanced Melanoma Clinical Trial
Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti_CTLA-4 Monoclonal Antibody (CheckMate 168)
Status: Enrolling
Updated: 12/18/2014
mi
from
Orlando, FL
Click here to add this to my saved trials
Stage III Unresectable or Stage IV Advanced Melanoma Clinical Trial
Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti_CTLA-4 Monoclonal Antibody (CheckMate 168)
Status: Enrolling
Updated: 12/18/2014
mi
from
Allentown, PA
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 10 66